BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death
Ko, H. J., Chiou, S. J., Tsai, C. Y., Loh, J. K., Lin, X. Y., Tran, T. H., Hou, C. C., Cheng, T. S., Lai, J. M., Chang, P. M. H., Wang, F. S., Su, C. L., Huang, C. Y. F. & Hong, Y. R., 2022 12月, 於: Cell Communication and Signaling.20, 1, 200.